These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Drug costs for patients with Parkinson's disease in two different European countries. Vossius C; Gjerstad M; Baas H; Larsen JP Acta Neurol Scand; 2006 Apr; 113(4):228-32. PubMed ID: 16542161 [TBL] [Abstract][Full Text] [Related]
25. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease. Antonini A; Mancini F; Canesi M; Zangaglia R; Isaias IU; Manfredi L; Pacchetti C; Zibetti M; Natuzzi F; Lopiano L; Nappi G; Pezzoli G Neurodegener Dis; 2008; 5(3-4):244-6. PubMed ID: 18322402 [TBL] [Abstract][Full Text] [Related]
26. Continuous dopaminergic stimulation--from theory to clinical practice. Antonini A Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S24-8. PubMed ID: 17702632 [TBL] [Abstract][Full Text] [Related]
27. [Systematic evaluation on influence of dopaminergic therapy: on motor complications in Parkinson's disease]. Zhou MZ; Liu ZG; Chen W; Lu LX; Wu JY; Qi C Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):438-44. PubMed ID: 19567089 [TBL] [Abstract][Full Text] [Related]
28. Treatment of Parkinson's disease in Thailand: review of the literature and practical recommendations. Bhidayasiri R; Ling H J Med Assoc Thai; 2009 Jan; 92(1):142-54. PubMed ID: 19260256 [TBL] [Abstract][Full Text] [Related]
35. Advances in the pharmacologic management of early Parkinson disease. Hauser RA; Zesiewicz TA Neurologist; 2007 May; 13(3):126-32. PubMed ID: 17495756 [TBL] [Abstract][Full Text] [Related]
36. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079 [TBL] [Abstract][Full Text] [Related]
38. [Reconsiderations in the treatment of Parkinson's disease with levodopa: some pharmacodynamic evidence]. Zappia M; Nicoletti A; Muñoz-S D; Tapia-Núñez J Rev Neurol; 2009 Jul 1-15; 49(1):33-40. PubMed ID: 19557698 [TBL] [Abstract][Full Text] [Related]
39. Economic Analysis of Deep Brain Stimulation in Parkinson Disease: Systematic Review of the Literature. Becerra JE; Zorro O; Ruiz-Gaviria R; Castañeda-Cardona C; Otálora-Esteban M; Henao S; Navarrete S; Acevedo JC; Rosselli D World Neurosurg; 2016 Sep; 93():44-9. PubMed ID: 27216925 [TBL] [Abstract][Full Text] [Related]
40. The costs and benefits of enhanced depression care to employers. Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]